Search for: "SUMMERS v. STATE" Results 5841 - 5860 of 6,218
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
30 Jun 2008, 10:43 am
In our correspondence, I used a phrase that seemed odd, on reflection, just after the decision in D.C. v. [read post]
27 Jun 2008, 2:05 pm
The Court is now in its summer recess. [read post]
27 Jun 2008, 10:04 am
: (The Invent Blog), Impressive work on history of ‘Happy Birthday’ and copyright protection: (Innovationpartners), Gender and copyright: (Patry Copyright Blog)   Events 1 July: US PLI: ‘Prior art & obviousness 2008: The PTO and CAFC perspective on patent law sections 102 & 103’ - New York: (Patent Docs), 1-2 July – C5 conference on intellectual asset management for high-tech industries – Paris: (c5-online.com), 2… [read post]
26 Jun 2008, 9:30 pm
Brief amicus curiae of United States (recommending holding of petition pending decision in MetLife v. [read post]
25 Jun 2008, 3:54 pm
The Supreme Court of Missouri unanimously ruled en banc in State of Missouri v. [read post]
24 Jun 2008, 2:49 pm
  The Court's 8-1 decision in Rothgery v. [read post]
24 Jun 2008, 12:21 pm
Franklin in the first paragraph of Franklin v. [read post]
23 Jun 2008, 8:20 pm
He was a 22-year old African-American male whose sexual knowledge was fairly immature, and during the summer of 2004, he briefly dry-humped two teenage mentees who were sleeping at his home. [read post]
20 Jun 2008, 1:31 pm
On appeal, his appointed counsel filed a brief, pursuant to Anders v. [read post]
20 Jun 2008, 10:01 am
I'm in Cincinnati: River City, Queen City--and even Clean City, which it gets either from being home to favorite son P&G, or from a tongue-in-cheek guilty hangover from the Simon Leis v. [read post]
20 Jun 2008, 8:07 am
: (Spicy IP), Latin America: Merck Serono signs distribution agreement with Bristol-Myers Squibb for portfolio of established pharmaceutical brands in Latin America: (IP tango), US: Biotech industry growth to slow due to funding pressures and competition from biosimilars: (Managing Intellectual Property), US: House Commerce Committee posts responses to its questions on biogenerics; not surprisingly, the views run the gamut: (FDA Law Blog), US: Biosimilar debate heats up at BIO: (Managing… [read post]